Fate Therapeutics, Inc. FATE
1.01 USD -0.04 (-3.81%)
Regular-session close
1.05 +0.04 +3.79%
After hours · Nov 19, 7:13 PM ET
1.01 Day range 1.07
0.95 52-week range 3.23
- YTD
- +3.06%
- 1 year
- -3.81%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 6.65M | 13.63M | 63.53M | 96.30M | 55.85M | |
| 6.65M | 13.63M | 63.53M | 96.30M | 55.85M | |
| -147.70M | -210.28M | -190.51M | -308.39M | -216.99M | |
| -136.31M | -186.26M | -160.93M | -281.72M | -212.15M | |
| -1.15 | -1.64 | -1.64 | -2.91 | -2.24 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 56.85M | 46.28M | 57.05M | 76.56M | 148.81M | |
| 318.94M | 440.69M | 506.22M | 705.56M | 921.46M | |
| 111.75M | 121.97M | 137.80M | 221.62M | 242.62M | |
| 77.85M | 85.27M | 103.54M | 109.34M | 114.82M | |
| 207.18M | 318.73M | 368.42M | 483.94M | 678.84M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -106.08M | -122.87M | -132.26M | -248.21M | -162.87M | |
| 111.17M | 12.22M | 112.67M | 166.75M | -324.02M | |
| 5.49M | 99.89M | 85.00K | 9.21M | 453.13M | |
| -5.59M | -730.00K | -6.15M | -35.57M | -50.70M | |
| 10.57M | -10.76M | -19.51M | -72.25M | -33.76M |
